Search Results 31-40 of 11406 for MOTS-c Analogue
VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore ...
New targeted therapies and other advances in the management of anaplastic thyroid cancer. Curr. Opin Oncol. 2013;25:44-9. 9. Brown RF, Ducic Y. Aggressive ...
Kusne Y, Badar T, Lasho T, Marando L, Mangaonkar AA, Finke C, Foran JM, Al-Kali A, Palmer J, Arana Yi C, Alkhateeb HB, Gangat N, Viswanatha D, Litzow MR, ...
difficile infection (CDI) after a primary episode and have completed at least two rounds of standard-of-care oral antibiotic therapy or have had at least two ...
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
2020; 72(2):88-94. Sharma U, Ghosh A. Culture of Safety. Minnesota Medical Journal. 2020 Jul/Aug; 103(4):44-7.
MRE determines the stiffness (fibrosis) of the liver in patients with hepatitis C without needlesticks. This technology makes treating liver disease easier ...
... C antibody [HepCAb], followed by hepatitis C virus RNA by PCR if HepCAb is positive). Subjects with a history of hepatitis B vaccination without history ...
Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy. Neurology. 2020 Sep 01; 95(9):e1244-e1256. Epub 2020 Jul 20.
... C-ENTERPRISES XMAYO1-CSU-5F. MC00 ########## N. 65788793 1 157096. X ETT ADHESIVE/INFINITY. 210506420 MANNINGTON MILLS INC. 02/19/2018. 1.00. GA. 88.70. 88.70 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.